Abonnez-vous pour accéder à l'ensemble des données
Entreprise Secteur d'activité Cap. boursière ($) # acheteurs nets Valeur nette achetée ($) % du flottant acheté % d'actions détenues par les initiés
Healthcare Services Mid (2.3bn) -6–10 -$10M–$100M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (2.3bn) 0 Aucune activité — —
Pharmaceuticals & Medical Research Mid (2.3bn) -1–5 -< $100K -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (2.3bn) 0 Aucune activité — 15–50%
Pharmaceuticals & Medical Research Mid (2.3bn) 0 Aucune activité — 0–15%
SE Vimian Group AB (VIMIAN)
Healthcare Services Mid (2.2bn) -1–5 $10M–$100M 50%+ 0–15%
Pharmaceuticals & Medical Research Mid (2.2bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (2.2bn) 0 Aucune activité — 15–50%
US Zymeworks Inc (ZYME)
Pharmaceuticals & Medical Research Mid (2.2bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (2.2bn) 0 Aucune activité — 15–50%
Healthcare Services Mid (2.2bn) -1–5 -$1M–$10M -0–15% 0–15%
US 89Bio Inc (ETNB)
Pharmaceuticals & Medical Research Mid (2.2bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (2.2bn) 0 < $100K 0–15% 50%+
Pharmaceuticals & Medical Research Mid (2.2bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (2.2bn) 0 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (2.2bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (2.2bn) -6–10 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (2.2bn) 0 Aucune activité — 15–50%
FR Orpea SA (ORP)
Healthcare Services Mid (2.1bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (2.1bn) 0 Aucune activité — 15–50%
BE Fagron NV (FAGR)
Pharmaceuticals & Medical Research Mid (2.1bn) 1–5 $100K–$1M 0–15% 0–15%
AU Ansell Ltd (ANN)
Healthcare Services Mid (2.1bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (2.1bn) 0 Aucune activité — 15–50%
CH Idorsia Ltd (IDIA)
Pharmaceuticals & Medical Research Mid (2.1bn) 0 Aucune activité — 15–50%
Pharmaceuticals & Medical Research Mid (2.1bn) 0 Aucune activité — 0–15%
SE AddLife AB (ALIF-B)
Pharmaceuticals & Medical Research Mid (2.1bn) 1–5 < $100K 0–15% 0–15%
Healthcare Services Mid (2.1bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (2.1bn) 0 Aucune activité — 0–15%
IN Shilpa Medicare Ltd (SHILPAMED)
Pharmaceuticals & Medical Research Mid (2.1bn) -1–5 -< $100K -0–15% 50%+
Pharmaceuticals & Medical Research Mid (2.1bn) -1–5 -$1M–$10M -0–15% 0–15%
US NuVasive Inc (NUVA)
Healthcare Services Mid (2.1bn) 0 Aucune activité — 0–15%
CH BB Biotech AG (BION)
Pharmaceuticals & Medical Research Mid (2.1bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (2.1bn) 0 Aucune activité — 15–50%
Pharmaceuticals & Medical Research Mid (2.0bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (2.0bn) 0 Aucune activité — 0–15%
Healthcare Services Mid (2.0bn) 0 Aucune activité — 15–50%
US Absci Corp (ABSI)
Pharmaceuticals & Medical Research Mid (2.0bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mid (2.0bn) -1–5 -< $100K -0–15% 0–15%
Healthcare Services Mid (2.0bn) 0 Aucune activité — 0–15%
IN Jubilant Pharmova Ltd (JUBLPHARMA)
Pharmaceuticals & Medical Research Mid (2.0bn) 0 Aucune activité — 50%+
SE Elekta AB (publ) (EKTA-B)
Healthcare Services Mid (2.0bn) 1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Small (2.0bn) -1–5 -$10M–$100M -0–15% 0–15%
Pharmaceuticals & Medical Research Small (2.0bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Small (2.0bn) 0 Aucune activité — 0–15%
Healthcare Services Small (2.0bn) 0 Aucune activité — 0–15%
US Quidel Corp (QDEL)
Healthcare Services Small (2.0bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Small (2.0bn) 0 Aucune activité — 50%+
GB Genus PLC (GNS)
Pharmaceuticals & Medical Research Small (1.9bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Small (1.9bn) 0 Aucune activité — 15–50%
Pharmaceuticals & Medical Research Small (1.9bn) 0 Aucune activité — 15–50%
Pharmaceuticals & Medical Research Small (1.9bn) 0 Aucune activité — 0–15%
Healthcare Services Small (1.9bn) 0 Aucune activité — 0–15%
Healthcare Services Small (1.9bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Small (1.9bn) -1–5 -$10M–$100M -0–15% 0–15%
Healthcare Services Small (1.9bn) 0 Aucune activité — 0–15%
FR Emeis SA (EMEIS)
Healthcare Services Small (1.9bn) 1–5 < $100K 0–15% 0–15%
Healthcare Services Small (1.9bn) 0 Aucune activité — 0–15%
Healthcare Services Small (1.8bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Small (1.8bn) 0 Aucune activité — 0–15%
Healthcare Services Small (1.8bn) -1–5 -$10M–$100M -0–15% 0–15%
US Septerna Inc (SEPN)
Pharmaceuticals & Medical Research Small (1.8bn) 0 Aucune activité — 0–15%
Healthcare Services Small (1.8bn) 0 Aucune activité — 15–50%
Pharmaceuticals & Medical Research Small (1.8bn) 0 Aucune activité — 0–15%
US Biohaven Ltd (BHVN)
Pharmaceuticals & Medical Research Small (1.8bn) 0 Aucune activité — 0–15%
BE Galapagos NV (GLPG)
Pharmaceuticals & Medical Research Small (1.8bn) 0 Aucune activité — 15–50%
Pharmaceuticals & Medical Research Small (1.8bn) 0 Aucune activité — 0–15%
US Novavax, Inc. (NVAX)
Pharmaceuticals & Medical Research Small (1.8bn) 0 Aucune activité — 0–15%
Healthcare Services Small (1.8bn) -6–10 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Small (1.8bn) 0 Aucune activité — 0–15%
Healthcare Services Small (1.8bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Small (1.8bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Small (1.8bn) 1–5 < $100K 0–15% 0–15%
US Luminex Corp (LMNX)
Healthcare Services Small (1.8bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Small (1.7bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Small (1.7bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Small (1.7bn) -1–5 -< $100K -0–15% 0–15%
Healthcare Services Small (1.7bn) -6–10 -$100K–$1M -0–15% 0–15%
Healthcare Services Small (1.7bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Small (1.7bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Small (1.7bn) 0 Aucune activité — 50%+
Pharmaceuticals & Medical Research Small (1.7bn) -1–5 -$100K–$1M -0–15% 15–50%
Pharmaceuticals & Medical Research Small (1.7bn) -1–5 -$10M–$100M -0–15% 50%+
Pharmaceuticals & Medical Research Small (1.7bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Small (1.7bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Small (1.7bn) 0 Aucune activité — 0–15%
Healthcare Services Small (1.7bn) -1–5 -$10M–$100M -0–15% 50%+
SE Ambea AB (publ) (AMBEA)
Healthcare Services Small (1.7bn) 1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Small (1.6bn) 1–5 $100K–$1M 0–15% 0–15%
Pharmaceuticals & Medical Research Small (1.6bn) 1–5 < $100K 0–15% 15–50%
Pharmaceuticals & Medical Research Small (1.6bn) 0 Aucune activité — 0–15%
Healthcare Services Small (1.6bn) 0 Aucune activité — 50%+
Pharmaceuticals & Medical Research Small (1.6bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Small (1.6bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Small (1.6bn) 0 Aucune activité — 0–15%
Healthcare Services Small (1.6bn) 0 Aucune activité — 0–15%
Healthcare Services Small (1.6bn) -1–5 -$1M–$10M -0–15% 50%+
Healthcare Services Small (1.6bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Small (1.6bn) 0 -$10M–$100M -0–15% 15–50%
US Innoviva Inc (INVA)
Pharmaceuticals & Medical Research Small (1.6bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Small (1.6bn) 0 Aucune activité — 0–15%